Givaudan | GIVN - Sales Revenues

Stock Price
2,789.00
Daily Change
-7.00 -0.25%
Monthly
-1.41%
Yearly
-23.96%
Q2 Forecast
2,645.61

Givaudan reported CHF3.61B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Air Liquide EUR 13.22B 6.62B Dec/2025
Akzo Nobel EUR 2.37B 180M Dec/2025
Anheuser-Busch USD 15.56B 430M Dec/2025
Arkema EUR 2.11B 80M Dec/2025
Associated British Foods GBP 9.95B 441M Sep/2025
BASF EUR 14.03B 300M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Beiersdorf EUR 2.31B 40M Dec/2025
British American Tobacco GBP 13.5B 1.43B Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Croda International GBP 825.73M 412.23M Dec/2025
Danone EUR 6.68B 200M Dec/2025
Diageo GBP 5.59B 3.76B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
Heineken EUR 14.57B 392M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
International Flavors Fragrances USD 2.59B 100M Dec/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Kerry EUR 3.88B 0 Dec/2024
Lonza CHF 3.58B 63M Jun/2025
L'Oréal EUR 21.58B 10.84B Dec/2025
Merck EUR 5.25B 70M Dec/2025
Nestle CHF 45.26B 1.03B Dec/2025
Pernod Ricard EUR 5.25B 2.87B Dec/2025
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
SGS CHF 3.46B 1.79B Dec/2024
Sika AG CHF 5.52B 151.5M Dec/2025
Solvay EUR 995M 45M Dec/2025
Tate & Lyle GBP 1.02B 0 Dec/2025
Umicore EUR 10.68B 8.89B Dec/2025
Victrex GBP 75.5M 70.4M Sep/2025